Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)32463-3
Abstract: Novel diabetes agents (glucagon-like-peptide-1 receptor agonists, GLP-1 RA and sodium-glucose cotransport-2 inhibitors, SGLT2i) reduced death and cardiovascular events in randomized trials, but uptake in clinical practice has lagged. We assessed the unrealized potential for reduction…
read more here.
Keywords:
potential unrealized;
diabetes agents;
unrealized cardiovascular;
novel diabetes ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.6_suppl.43
Abstract: 43Background: ARTAs (enzalutamide and abiraterone) have been approved for relapse of prostate cancer in Japan since 2014. However, the efficacy of ARTAs for overall survival (OS) has not yet been p...
read more here.
Keywords:
receptor targeting;
world benefit;
benefit novel;
novel androgen ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph20032300
Abstract: (1) Background: We present the protocol of a randomized controlled trial designed to evaluate the benefit of a novel clinical decision support system for the management of patients with COVID-19. (2) Methods: The study will…
read more here.
Keywords:
system;
randomized controlled;
novel clinical;
controlled trial ... See more keywords